---
schema_version: "secwatch.filing_event.v1"
accession: "0001607062-22-000013"
form_type: "8-K"
ticker: "RGBP"
cik: "0001589150"
company_name: "Regen BioPharma Inc"
filed_at: "2022-01-14T23:59:59+00:00"
generated_at: "2026-06-27T17:57:08.354195+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Regen Biopharma subleases office space from BST Partners controlled by CEO David Koos at $5,000/month

## Summary
- Entered into month-to-month sublease with BST Partners for office space at 4700 Spring Street, Suite 304, La Mesa, CA starting January 14, 2022.
- Monthly rent of $5,000 payable to BST Partners, which is controlled by David Koos, Regen's sole officer and director.
- Sublease creates a direct financial obligation and is a related-party transaction due to Koos's control of both entities.

## SEC filing metadata
- accession: 0001607062-22-000013
- form_type: 8-K
- ticker: RGBP
- cik: 0001589150
- company_name: Regen BioPharma Inc
- filed_at: 2022-01-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000013/0001607062-22-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1589150/000160706222000013/rgbp011322form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001607062-22-000013
- JSON: https://secwatch.observer/filing/0001607062-22-000013.json
- Plain text: https://secwatch.observer/filing/0001607062-22-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.